Skip to main content
Equibles

TWO SIGMA INVESTMENTS, LP

Position in SMMT — Summit Therapeutics Inc.

CIK 1179392 NEW YORK, NY
Back to SMMT Full portfolio

Position in SMMT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$10,151,122
-$8,452,145 QoQ
Shares Held
696,714
-29.0% QoQ
Ownership
0.087%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#32
of 242 holders
Holding Since
Dec 2022
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SMMT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TWO SIGMA INVESTMENTS, LP holds $7,283,390,440 across 343 Biotechnology names. SMMT ranks #86 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALNY
Alnylam Pharmaceuticals, Inc.
 1,875,937 $564,713,315
2 MRNA
Moderna, Inc.
 7,193,530 $503,762,905
3 IONS
Ionis Pharmaceuticals Inc
 6,252,342 $495,748,197
4 REGN
Regeneron Pharmaceuticals, Inc.
 656,124 $409,119,558
5 BBIO
BridgeBio Pharma, Inc.
 4,722,185 $351,708,338
6 EXEL
Exelixis, Inc.
 4,209,861 $229,058,537
7 INCY
Incyte Corp
 2,003,559 $227,123,448
8 ARGX
Argenx SE
 185,638 $172,229,367

All Filings in SMMT

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,151,122 696,714
2026-03-31 $18,603,267 981,185
2025-12-31 $10,113,557 578,248
2025-09-30 $517,119 25,030
2024-03-31 $97,617 23,579
2023-12-31 $277,127 106,179
2023-09-30 $198,554 106,179
2023-06-30 $456,767 181,979
2023-03-31 $902,891 515,938
2022-12-31 $1,216,350 286,200